Siemens Healthineers Widens FY25 EPS Range By €0.15 To Absorb Up To €300M In Tariff Costs

Selective Exposure Allows Diagnostics To Avoid Major Disruptions From Europe-US And US-China Trade Tensions.

Siemens Healthineers CEO Bernhard Montag said the company is well-positioned to adapt, but visibility is required for longer-term investment decisions. (Shutterstock)

More from Strategy

More from Medtech Insight